SWARTZ ROBIN (Chief Operating Officer) sold 5.5% of their position (6.50K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $36.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/26/2024ACC: 0001104659-24-131725
Officer· Chief Operating Officer
Since Feb 2022
-6.50K
Net shares
Net seller
$36.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.50K
Price / share
$5.65
Trade value
$36.73K
% of position
5.5%
12/23/2024
118.83K→112.33K
Total
Net shares
−6.50K
Net value
-$36.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2024 | S · Sale | −6.50K | $5.65 | $36.73K | 5.5% | 118.83K | 112.33K |
| Total | −6.50K | -$36.73K | ||||||
Derivative Transactions0
No derivative transactions reported